참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | L-Methionine | HCID 6137 | — |
| 반응물 | Methanesulfonic Acid | HCID 6395 | — |
| 반응물 | 2-[4-(4-Methoxy-phenoxy)-phenyl]-[1,3,4]oxadiazole | HCID 20636234 | — |
| 용매 | Sodium Bicarbonate | HCID 516892 | — |
| 생성물 | 4-(4-[1,3,4]Oxadiazol-2-yl-phenoxy)-phenol | HCID 20636235 | 87.3% |
반응 단계
A mixture of 2-[4-(4-Methoxy-phenoxy)-phenyl]-[1,3,4]oxadiazole (1.1 g, 4.1 mmol), methionine (0.94 g, 4.9 mmol) and methanesulfonic acid (20.5 mL) was heated to 50° C. for 1.5 hours. The mixture was poured into ice cold 5M sodium hydroxide solution (60 mL), diluted with sodium bicarbonate solution (saturated aqueous), and was extracted three times into ethyl acetate. The combined organic phases were dried over sodium sulfate (Na2SO4), filtered and concentrated in vacuo, affording 4-(4-[1,3,4]oxadiazol-2-yl-phenoxy)-phenol as a colorless solid (0.91 g).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06706723B2 |
|---|
| 출처 데이터셋 | uspto-grants-2004_03 |
|---|
| ORD ID | ord-0d42d15a12cb4d7cabd141e5b7258afd |
|---|
| 출처 메모 | uspto-grants-2004_03 |
|---|